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Are pharmacists really “Playing Doctor” as a popular NBC show described the Mississippi
Medicaid Pharmaceutical Care project? No, but the bottom line of the NBC show was that
pharmacists are changing their practice habits to compensate for the decreased rate of return on
filling prescriptions. In reality, pharmacists are neither “playing” physician nor merely trying to
pad their pockets with a newfound source of income. While it is true that pharmacists are
changing their practice habits, they are doing so for the betterment of their patients’ drug therapy
outcomes and the healthcare system. The pharmacist serves as the vital link between the patient,
physician, and healthcare system. By working with patients and physicians, pharmacists have
demonstrated in the literature that they can improve patient drug therapy outcomes, thus
preventing unnecessary healthcare expenditures (Fincham, 1998). Pharmacists have long been
held in highest esteem by patients, being voted the number one trusted professional for 10
consecutive years. The evidence is clear that pharmacists provide a valuable service to their
patients and healthcare programs, thus they should be adequately compensated. It is important
for physicians, healthcare plans, and pharmacists to have a clear idea for what pharmacists are
being compensated.
For what services should pharmacists be paid? Cognitive reimbursement is a term used
to describe payment for non-product-related services. These services involve critical thought
processes applied to the appropriateness of medications used by patients. The term and practice
has quickly evolved, as it is apparent that no one is going to pay pharmacists to simply think
about patient care. Payers and patients are ready to pay for what pharmacists can DO to improve
patient outcomes. The concept of Pharmacist Care or Pharmaceutical Care emerged to focus the

pharmacist on all aspects of the delivery of care to patients. Three major categories of
reimbursed services are widely recognized: resolution of drug therapy problems, disease state or
health management, and extensive patient self-management training and education. Other areas
where pharmacists have been successful billing for services are health promotion and disease
prevention. Table 1 illustrates the variety of health care areas in which services are provided by
pharmacists around the country (Felkey, 1999). The payment for professional prescription filling
ensures the safety of a product dispensed and OBRA90 or California mandated counseling. The
provision of pharmaceutical care services by a pharmacist is over and above any state or national
requirements and warrants appropriate additional remuneration.
The Healthcare Picture
In California, managed care is incorporated into virtually all health insurance plans. The
number of fee-for-service enrollees has steadily declined as a cost conscious society prepares for
the next millennium. Under managed care, a health plan contracts with specific providers and
pays them a capitated payment or a discounted fee-for-service amount. Typically, providers are
expected to assume some financial risk for high cost health care under risk sharing arrangements.
Providers may also share some savings if the care provided is less costly than anticipated.
Maintaining high quality health care is important to employers who, along with the government,
are the major purchasers of health care in the U.S. New National Committee on Quality
Assurance (NCQA) measures compare various health plans on important aspects of the care
provided. Thus maintaining high quality care at the most cost-effective level is an important goal
of managed care.

The number of patients paying the entire cost of prescriptions has also decreased as managed
care plans grow. Health plans covering prescription benefits increasingly use formularies and
other utilization controls to maintain reasonable per member per month (PMPM) prescription
costs. Most prescription benefits are managed by pharmacy benefit managers (PBMs) in the
form of separate companies or divisions within a health insurance company.
Who are the Payers of Pharmaceutical Care Services?
Value is at the core of determining who will pay for pharmacist care services. For
example, if pharmacists take part in an ACE inhibitor preferred product interchange program, an
insurer may find this valuable and pay pharmacists for this activity. On the other hand, patients
may not find this service of particular value especially if the cost of the medication to the patient
does not change. Thus if a pharmacist were to ask a patient to pay for this service, it would likely
be unsuccessful. On the other hand, a travel medicine clinic that helps patients prepare for
foreign travel on vacation or for business might be of value to patients, but of less interest to the
health plan.
Potential sources of reimbursement include patients and their families, insurance
companies, medical groups, individual physicians, pharmacy benefit managers, manufacturers,
employer groups, hospitals, home health care agencies, assisted living centers, and the
government. Patients are an important group because, as consumers, they are a driving force
behind what services employers demand of insurers, the services insurers provide to stay
competitive, and services the government will provide to the voting constituency. Table 2 lists
some current and potential sources of payment for pharmacist services in California (please help

us complete this table by faxing us your sources of payment in the survey at the end of this
article).
Methods of Payment and Setting Fees
Several mechanisms have been used to determine what to charge and how to pay for
pharmacists’ services. Some payment methods used to pay pharmacists and other healthcare
providers include fee-for-service, per capita (capitated) payments, fees based on cost savings
realized, and resource based relative-value scales (RBRVS). Methods for payment of
pharmacists are evolving. As more is known about the costs and benefits of pharmaceutical care,
the methods of payment will evolve as well. As in the early days of paying physicians a fee-forservice, this method is now the most common payment method in California for payment of
pharmaceutical care services. Tempting as it may seem as a method for payment, fees based on
cost savings realized may be severely reduced after initial year savings are squeezed out of the
system. It is likely that a combination of fee-for-service and capitated methods will emerge once
pharmaceutical care is widely practiced.
Pharmacists use a variety of methods to determine how much to charge for a particular
service. Under the fee-for-service method, a flat rate is set for a particular service or fees are
charged based on an hourly rate. For example, some pharmacists charge $60/hour and then break
the fee down into 10 minute increments depending on the length of the visit. Others may charge
a flat rate depending on the type of service and level of complexity. For instance, a pharmacist
might charge one fee (e.g. $100) for an initial asthma work-up and then a lower (e.g. $25) fee for
each follow-up visit. Mixing these two methods may continue to be a common practice. The flat
rate service fee works for standardized services such as disease state management and an hourly

fee might work better for drug therapy problem resolution and services where time requirements
are more variable. An important factor in setting rates is the cost of providing the service. The
cost of the pharmacist’s time, space utilization, and other costs should be considered when
setting fees. Additionally, competition between pharmacists and from other providers will play
an important role in what pharmacists charge. The key to setting fees is to set them before
marketing a service, in-service staff on the fee structure, and then let the patient know how much
the care is going to cost before providing the service.
Non-distributive pharmacy services are not currently provided under a typical managed care
capitated structure. As pharmacists continue to demonstrate the ability to effect positive patient
outcomes, capitated methods to pay for pharmaceutical care may soon become reality. A patientbased capitated approach is used by some pharmacists to charge the patient or family a yearly fee
that covers them regardless of number of times seen. However, the inability to adjust fees
midyear if a patient’s care becomes more labor intensive than originally estimated is a downside
to the patient -based capitated program.
Finally, the most complicated system, but possibly the most accurate, is the resource-based
relative value scale (RBRVS). This pricing system is used by Medicare and some third party
payers to pay for services by accounting for differences in the complexity of a patient visit. In
this complex system, relative value units are assigned to a service based on current procedural
terminology (CPT) and other codes. At this moment, not enough is known about the time
requirements and benefits or the range of possible services provided by pharmacists to accurately
determine a RBRVS for pharmacists providing care in the community pharmacy.

Some services provided by pharmacists will not be covered or paid by insurers. Thus, the
pharmacist must decide if patients will be billed for unreimbursed amounts. Additionally, full
payment could be collected from the patient and then the patient submits the claim to the insurer.
Whichever method is chosen, the pharmacist should have a plan to charge patients for care the
day the service begins and make it clear to the patient how the process will work prior to
delivering services.
Steps in Billing (see Figure 1)
Data Gathering-Once the pharmacy environment is ready for pharmaceutical care and a
documentation method is in place, the pharmacist is ready to work with the patient and the
patient’s physician. The information gathered during a patient interview or a patient-completed
history form includes not only a medication history, but also a complete medical history. The
first step in the rather simple process of billing is to collect information from the patient
regarding insurance plans. This information can be obtained along with the complete medical
history. Both pharmacy benefits and medical benefits information should be obtained from the
patient. If the patient does have insurance, a statement that allows the pharmacist to accept
assignment of benefits on the patient’s behalf for the services to be provided should be signed.
The pharmacist could also include a statement obligating the patient to accept responsibility for
any portion of the bill that the insurance company does not reimburse. If the service provided is
a disease management related service, and if the patient does not have medical insurance with a
fee-for-service plan, the patient should be informed that they are responsible for the total amount
of care provided. If the patient has a managed care plan, the primary physician group may be
responsible for all medical care services provided to the patient, including those disease

management services provided by pharmacists. In this case, the pharmacist should talk to the
medical group about the value of the services provided. If the pharmacist has identified a drug
specific problem, such as non-compliance, the pharmacy benefit management company might
provide payment.
Documentation-Documentation of patient care activities is vital to reimbursement. If you
didn’t document it, you didn’t do it! The type of documentation required for pharmaceutical care
does not go on the back of a prescription, which makes it episodic and strictly drug related, nor
can it simply be entered into many distribution-only systems. Separate patient charts or a
documentation computer system must be used to adequately track patient care. By documenting
patient care activities, a continuous record is created that allows each pharmacist to have an
accurate and updated picture of the healthcare of every patient. In addition, during a third party
payer audit, evidence of the care provided should easily be retrievable. To enhance the ability to
gather and share information with other health care providers, the patient should sign a statement
(usually at the end of the patient history form) allowing the release of medical information
necessary for providing pharmaceutical care services and processing payment from a third party
payer. A drug therapy problem or healthcare need may arise from the data gathering stage or a
previously identified one. The resolution and follow-up of this patient care need or problem
forms the basis of the billable event.
Medical Necessity-A medical necessity form serves several purposes and should be obtained
before scheduled care is to be provided. The first purpose is to inform the patient’s physician of
the care the patient needs. The second purpose is to inform the medical insurance company that
the care provided is considered by the physician to be a necessary part of the patient’s medical

care. Since the same diagnosis (ICD-9) codes that the physician uses for billing are used, the
medical necessity form provides a place for the ICD-9 code and diagnosis to be entered by the
physician or office staff. Pharmacists must use the ICD-9 code assigned to that patient by the
physician. It should not be left blank on the billing form or indirectly determined from the
diagnosis. If the physician signs and approves of the medical necessity, it may be prudent to call
the medical insurance company for prior authorization. However, since pharmaceutical care is
still a new concept to insurers, gaining prior authorization may be difficult. The goals at this
point are to determine what type of coverage the patient has, if the insurer covers referred
specialists, the patient’s deductible and if its been met, and the process for submitting a claim (if
you have not previously submitted a claim for this insurer). Assuming prior authorization is
obtained, the patient is ready to be seen. Obtaining the medical necessity and prior authorization
take time and are most appropriate for scheduled visits.
Billing Submission-At the completion of patient care, activities are documented and follow-up
care is scheduled if necessary. Contacting the payer to request prior authorization for a service
may increase success in billing. It is important to include in the dialogue with the payer that “the
primary care physician has asked me [as a referred specialist] to instruct the patient on selfmonitoring of their disease”. Currently there is no universally used on-line adjudication system
for processing pharmaceutical care claims. Thus promptly submitting forms for reimbursement
after the patient encounter is important for the economic viability of the service. If a disease
management service has been provided, the medical necessity form should be sent along with the
HCFA-1500 billing form to the medical insurer. The HCFA-1500 can be completed either
manually or by using one of the commercially available computer programs (Poirier, 1999;

Rudolph, 1997). It should be clear on this form that a pharmacist is providing the service because
physician CPT codes are used. Just like a dietician or podiatrist, the pharmacist is a referred
specialist performing a service requested by the primary care physician. If the care provided is the
resolution of a specific drug problem, for example compliance with a medication, some sources
recommend using the National Community Pharmacists Association (NCPA) Pharmacist Care
Claim form (Poirier, 1999; Rudolph, 1997). This form collects specific data about the problem,
action, result, time and specific drug(s) involved. Whatever the form used and payer contacted,
allow about one month for processing of claims before calling the third party payer about
unresolved claims. Patience and perseverance will be rewarded.
Keys to Success
Billing for pharmaceutical care services requires different procedures, a patient focused
environment, and the right mindset. In traditional reimbursement, pharmacists are paid for
dispensing a product. This service is usually paid by the pharmacy benefits portion of the
patient’s insurance coverage or by the patient directly. In pharmaceutical care, the pharmacist is
often billing the medical benefits provider rather than the pharmacy benefits provider for a
service rather than a drug.
The provision of pharmaceutical care services requires all the pieces of the puzzle to be
effective (Johnson, 1997): an appropriate patient care area, efficient workflow, effective use of
ancillary personnel, written policy and procedures, training, documentation, a marketing and
reimbursement strategy, and outcomes management. Figure 2 describes some practical “do’s and
don’ts” of reimbursement. An important trap to avoid is the saying, “I’m not going to do it until
I get paid for it” because payers have another saying, “we’re not going to pay you until you’re

doing it”. Providing pharmaceutical care is a result of the natural evolution of our profession and
getting paid for that service is merely the next step.

Figure 2
Reimbursement Practice Points
DOs

 Start with a reasonable marketing plan and stick to it
 Establish fees before you start a service
 Provide a service that patients need and you enjoy doing
 Make sure you can perform the service and do it well
 Be very familiar with the procedures payers require for reimbursement
 Verify medical coverage for your procedure and get authorization if possible
 Be persistent and resubmit rejected claims!
DON’Ts

 Don’t send your patient care documentation forms in with your reimbursement forms
 Don’t omit any boxes that need to be filled in on the HCFA-1500 form
 Don’t bill the pharmacy benefits division of the third party payer for disease management
services

Key terms used in this article or in billing
 CPT (Common Procedural Terminology)
 ICD-9 (International Classification of Diseases, 9th Revision)
 UPIN (Universal Provider Identification Number)
 RBRVS (Resource-based Relative Value Scale)
 HCFA (Health Care Financing Administration)
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Table 1. Topic Areas of Pharmacist Services Where Reimbursement is Obtained Across the United States
Addiction
Administration
Allergy & Flu
Alternative Medicine
Anti-Coagulation
Asthma
Cancer
Cholesterol
Compliance
Compounding
Counseling
Diabetes
Disease Management
Drug Monitoring
Drug Information
Felkey, 1999

Fertility
HIV/AIDS
Home Infusion
Home Visit/Delivery
Hormone Replacement
Hyperlipidemia
Hypertension
Immunization
In-House Pharmacy
Long Term Care
Nuclear Medicine
Nutrition
Pain Management
Patient Education
Pharmaceutical Care

Pharmacy Groups
Professional Education
Robotics
Self Care
Smoking Cessation
Software
Travel Clinic
Weight Loss
Wellness
Women's Health
Workman's Compensation
Workflow Simulation
World Wide Web

Figure 1 Pharmaceutical Care Billing Procedure-for Fee-for-Service or Self-Pay Patients
Obtain Medical and
Pharmacy
Insurance
Information

Check insurance
coverage to see
if service is a
covered benefit

Yes, covered
benefit
Obtain patient
signature for
release of
information

Provide and
Document
patient care

Complete and
submit HCFA1500 or other
required claim
form and
Medical
Necessity if
required

Follow-up on
submitted claim

Not covered, bill
patient directly
for services
provided

Determine if need
medical necessity
from physician
for insurance
billing

Table 2
Pharmaceutical Care Reimbursement Projects in California for Community Pharmacists
Disease
Asthma

Payer
Blue Cross of California

Diabetes and Asthma

research project
supports

Immunizations

patient self pay,
Medicare

Anticoagulation

physician group

Anticoagulation,
dyslipidemia, GERD,
PUD, hypertension,
asthma, and diabetes

research project
supports first year,
thereafter physician
group supports

Positive Outcomes
Program

County of Monterey
County of Kern
OMNI Healthcare
Sutter Preferred
VEBA

Diabetes

CalOPTIMA

Comments
high risk patients
identified by payer and
pharmacists paid $25 per
visit up to 4 visits/year
Pharmacist must be
identified as a provider
by taking approved
coursework
MediCal patients
identified for a pilot
project*
Pharmacists paid for
providing disease state
management for high
risk fee-for-service
MediCal patients in 7
counties
Pharmacist must be
identified as a provider
by meeting certain
requirements
multiple pharmacists
provide immunization
services
pay percentage of
pharmacist salary for
specific clinic visits
Medical group
demonstration project**
Pharmacist paid to
manage identified high
risk patients over 1 year
for a group of primary
care physicians.
adjudicated through
PCN
Pharmacist paid a $10
fee for approved
submission of a
prescription or drug
therapy problem
adjudicated through
PCN
Pharmacist paid $5 fee
for providing Diabetes
Retinal Eye Exam
Reminder

Diabetes

patient self pay, various
various pharmacists
health care plans on a
provide care and are
patient specific need
paid for services by
basis
patients and health plans
* proposed project-Contact Carlo Michelotti, CPhA for more information
**proposed project-Contact Kathy Johnson, USC for more information

Survey of Pharmacist Care Reimbursement in California
Please take a moment to complete this survey. We find there is a general lack of comprehensive information about
what services are being paid for and by whom in California. All information will be kept confidential. Only
compiled information, not individual responses will be published. We will publish the summary results in a future
issue of the Journal. You may fax your results to Kathy Johnson, Pharm.D., Ph.D. (323) 442-1462 or via email:
kjohnson@hsc.usc.edu Thank you!

1.

What services are reimbursed and for what diseases?

2.

What patients are eligible for the services?

3. How much is charged? How much is paid? What is the method of payment (eg flat fee, capitated rate, etc)

4.

How do you submit your claim for processing (eg paper claim using the HCFA-1500, NCPA Pharmacist Care
Claim Form, Specific billing form provided by company (fax us an example), etc)

5. Who pays for the services (what company and/or health plan)? To whom is the claim submitted?

6.

Are there special requirements a pharmacist must meet in order to be a provider? What are the requirements?

7.

Pharmacist Name, address, phone, fax (in case we must clarify your responses) (this information will be kept
confidential)

Thank you for your input.
FAX your information to: Kathy Johnson 323-442-1462

Mississippi Medicaid Project:
The state of Mississippi has reacted to its extremely high fee for service emergency room costs by implementing a
special pharmacist initiative. The Health Care Financing Administration (HCFA) has granted a 2 ½ year waiver to
compensate pharmacists for specific disease management services. Four disease states have been selected for
pharmacist management. They include: anticoagulation, asthma, dyslipidemia and diabetes. Pharmacists must pass
a disease specific credentialing exam, administered by the National Association of Boards of Pharmacy (NABP), and
take hands on training from approved providers in order to receive payment for their services. Pharmacists must also
obtain physician referral, via a medical necessity form for each patient they feel is a candidate for their services. A
limited number of visits (10) are allowed per patient per year. The fee paid per visit is $20. An analysis of the
impact of the project are due at the end of the demonstration period.

